8-91127095-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001129890.2(LRRC69):c.318A>T(p.Leu106Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000301 in 1,395,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001129890.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC69 | NM_001129890.2 | c.318A>T | p.Leu106Phe | missense_variant | 3/8 | ENST00000448384.3 | NP_001123362.1 | |
LRRC69 | NM_001354470.2 | c.183+24251A>T | intron_variant | NP_001341399.1 | ||||
LRRC69 | NR_148895.2 | n.563A>T | non_coding_transcript_exon_variant | 3/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC69 | ENST00000448384.3 | c.318A>T | p.Leu106Phe | missense_variant | 3/8 | 5 | NM_001129890.2 | ENSP00000400803 | P1 | |
LRRC69 | ENST00000343709.7 | c.183+24251A>T | intron_variant | 2 | ENSP00000343221 | |||||
LRRC69 | ENST00000520099.5 | c.*310A>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/11 | 2 | ENSP00000428537 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000268 AC: 4AN: 149154Hom.: 0 AF XY: 0.0000126 AC XY: 1AN XY: 79402
GnomAD4 exome AF: 0.0000301 AC: 42AN: 1395016Hom.: 0 Cov.: 30 AF XY: 0.0000276 AC XY: 19AN XY: 688136
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2023 | The c.318A>T (p.L106F) alteration is located in exon 3 (coding exon 3) of the LRRC69 gene. This alteration results from a A to T substitution at nucleotide position 318, causing the leucine (L) at amino acid position 106 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at